U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07723716) titled 'Evaluate the Efficacy and Safety of CTO0307 in Adults With Presbyopia' on July 19.
Brief Summary: This study was to compare the presbyopia correction effect between the treatment group and the control group, evaluated by the proportion of patients who achieved an improvement of 3 lines or more in mesopic binocular DCNVA at 3 hours post-dose after 4 weeks of administration of the investigational product.
Study Start Date: Feb. 26, 2025
Study Type: INTERVENTIONAL
Condition:
Presbyopia
Intervention:
DRUG: CTO0307
Pilocarpine Eye drop
OTHER: Placebo
Vehicle
Recruitment Status: COMPLETED
Sponsor: Taejoon Pharmaceutical Co., Lt...